Voyager Therapeutics Inc. said Steven Paul will step down from the positions of president and CEO to become executive science adviser.
Paul is a founder of Voyager, initially serving as president of R&D and later as president and CEO since September 2014. He will continue to serve as CEO while the board searches for his replacement.
The developer of gene therapy added that Paul will continue to serve on the board.
